Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab Article

Custodio, A, Carmona-Bayonas, A, Jimenez-Fonseca, P et al. (2017). Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab . British Journal of Cancer, 116(12), 1526-1535. 10.1038/bjc.2017.122

Open Access

cited authors

  • Custodio, A; Carmona-Bayonas, A; Jimenez-Fonseca, P; Sanchez, ML; Viudez, A; Hernandez, R; Cano, JM; Echavarria, I; Pericay, C; Mangas, M; Visa, L; Buxo, E; Garcia, T; Rodriguez Palomo, A; Alvarez Mancenido, F; Lacalle, A; Macias, I; Azkarate, A; Ramchandani, A; Fernandez Montes, A; Lopez, C; Longo, F; Sanchez Bayona, R; Limon, ML; Diaz-Serrano, A; Hurtado, A; Madero, R; Gomez, C; Gallego, J

sustainable development goals

authors

publication date

  • June 6, 2017

published in

keywords

  • ADVANCED GASTRIC-CANCER
  • HER2
  • Life Sciences & Biomedicine
  • MODEL
  • Oncology
  • PROGNOSTIC-FACTORS
  • Science & Technology
  • VALIDATION
  • advanced oesophagogastric adenocarcinoma
  • nomogram
  • overall survival
  • polychemotherapy
  • web-based calculator

Digital Object Identifier (DOI)

start page

  • 1526

end page

  • 1535

volume

  • 116

issue

  • 12